Abstract:ABSTRACT Heteroresistance refers to phenotypic heterogeneity of microbial clonal populations under antibiotic stress, and it has been thought to be an allocation of a subset of “resistant” cells for surviving in higher concentrations of antibiotic. The assumption fits the so-called bet-hedging strategy, where a bacterial population “hedges” its “bet” on different phenotypes to be selected by unpredicted environment stresses. To test this hypothesis, we constructed a heteroresistance model by introducing a blaCTX-M-14 gene (coding for a cephalosporin hydrolase) into a sensitive Escherichia coli strain. We confirmed heteroresistance in this clone and that a subset of the cells expressed more hydrolase and formed more colonies in the presence of ceftriaxone (exhibited stronger “resistance”). However, subsequent single-cell-level investigation by using a microfluidic device showed that a subset of cells with a distinguishable phenotype of slowed growth and intensified hydrolase expression emerged, and they were not positively selected but increased their proportion in the population with ascending antibiotic concentrations. Therefore, heteroresistance—the gradually decreased colony-forming capability in the presence of antibiotic—was a result of a decreased growth rate rather than of selection for resistant cells. Using a mock strain without the resistance gene, we further demonstrated the existence of two nested growth-centric feedback loops that control the expression of the hydrolase and maximize population growth in various antibiotic concentrations. In conclusion, phenotypic heterogeneity is a population-based strategy beneficial for bacterial survival and propagation through task allocation and interphenotypic collaboration, and the growth rate provides a critical control for the expression of stress-related genes and an essential mechanism in responding to environmental stresses. IMPORTANCE Heteroresistance is essentially phenotypic heterogeneity, where a population-based strategy is thought to be at work, being assumed to be variable cell-to-cell resistance to be selected under antibiotic stress. Exact mechanisms of heteroresistance and its roles in adaptation to antibiotic stress have yet to be fully understood at the molecular and single-cell levels. In our study, we have not been able to detect any apparent subset of “resistant” cells selected by antibiotics; on the contrary, cell populations differentiate into phenotypic subsets with variable growth statuses and hydrolase expression. The growth rate appears to be sensitive to stress intensity and plays a key role in controlling hydrolase expression at both the bulk population and single-cell levels. We have shown here, for the first time, that phenotypic heterogeneity can be beneficial to a growing bacterial population through task allocation and interphenotypic collaboration other than partitioning cells into different categories of selective advantage.

Phenotypic Plasticity of Antibiotic Resistance, Metabolism Byproduct Utilization and the Evolution of Mutually Beneficial Cooperation in Escherichia Coli

Modeling the Role of Altruism of Antibiotic-Resistant Bacteria.

HORIZONTAL GENE TRANSFER AND THE EVOLUTION OF BACTERIAL COOPERATION

Comprehensive Genomic Investigation of Coevolution of mcr genes in Escherichia coli Strains via Nanopore Sequencing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia Coli under Translation‐Inhibiting Antibiotics

Emergent antibiotic persistence in a spatially structured synthetic microbial mutualism

The Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics

Spatial coordination in a mutually beneficial bacterial community enhances its antibiotic resistance

A 'rich-get-richer' mechanism drives patchy dynamics and resistance evolution in antibiotic-treated bacteria

Plasticity and stereotypic rewiring of the transcriptome upon bacterial evolution of antibiotic resistance

Coupled environmental and demographic fluctuations shape the evolution of cooperative antimicrobial resistance

High-Throughput Evolution Unravels Landscapes of High-Level Antibiotic Resistance Induced by Low-Level Antibiotic Exposure

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Antibiotic dose and nutrient availability differentially drive the evolution of antibiotic resistance and persistence

Colonization of Gut Microbiota by Plasmid-Carrying Bacteria is Facilitated by Evolutionary Adaptation to Antibiotic Treatment

Evolutionary trajectories of resistant mutants during sub-MIC antibiotic exposure

Phenotypic resistant single-cell characteristics under recurring ampicillin antibiotic exposure in Escherichia coli

Heteroresistance at the Single-Cell Level: Adapting to Antibiotic Stress Through a Population-Based Strategy and Growth-Controlled Interphenotypic Coordination

Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli

Eco-evolutionary dynamics of cooperative antimicrobial resistance in a population of fluctuating volume and size

Mechanisms of Staphylococcus Aureus Antibiotics Resistance Revealed by Adaptive Laboratory Evolution